Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
67%(6 trials)

Phase Distribution

Ph phase_3
3
25%
Ph phase_4
5
42%
Ph phase_2
2
17%
Ph phase_1
2
17%

Phase Distribution

2

Early Stage

2

Mid Stage

8

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
2(16.7%)
Phase 2Efficacy & side effects
2(16.7%)
Phase 3Large-scale testing
3(25.0%)
Phase 4Post-market surveillance
5(41.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(9)
Terminated(1)
Other(2)

Detailed Status

Completed9
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (16.7%)
Phase 22 (16.7%)
Phase 33 (25.0%)
Phase 45 (41.7%)

Trials by Status

unknown217%
withdrawn18%
completed975%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials
NCT00393276Phase 1

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

Completed
NCT01126853Phase 4

Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders

Withdrawn
NCT00289731Phase 4

Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc

Completed
NCT02334462Phase 1

Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali

Completed
NCT00684671Phase 4

Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination

Completed
NCT00289770Phase 3

Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults

Completed
NCT00465816Phase 3

Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612

Completed
NCT00107042Phase 2

Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths

Completed
NCT00603252Phase 4

Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults

Completed
NCT00316303Phase 2

Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder

Completed
NCT01451801Phase 4

Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders

Unknown
NCT00451984Phase 3

Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2

Unknown

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12